AU Stock MarketDetailed Quotes
RAD Radiopharm Theranostics Ltd
- 0.024
- 0.0000.00%
20min DelayMarket Closed Nov 1 14:50 AET
52.15MMarket Cap-193P/E (Static)
0.026High0.024Low1.36MVolume0.026Open0.024Pre Close35.09KTurnover0.10052wk High0.13%Turnover Ratio2.17BShares0.02352wk Low-0.124EPS TTM24.52MFloat Cap0.495Historical HighLossP/E (Static)1.02BShs Float0.023Historical Low-0.124EPS LYR8.33%Amplitude--Dividend TTM1.85P/B1Lot Size--Div YieldTTM
Radiopharm Theranostics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|
| Total revenue | 2.35%299.23K | 3,210.60%292.36K | 8.83K |
| Operating revenue | 2.35%299.23K | 3,210.60%292.36K | --8.83K |
| Cost of revenue | |||
| Gross profit | 2.35%299.23K | 3,210.60%292.36K | 8.83K |
| Operating expense | 6.09%36.92M | 74.66%34.8M | 19.93M |
| Selling and administrative expenses | 16.87%15.22M | 20.03%13.02M | --10.85M |
| -General and administrative expense | 16.87%15.22M | 20.03%13.02M | --10.85M |
| Research and development costs | 27.24%17.56M | 234.58%13.8M | --4.12M |
| Depreciation amortization depletion | -5.16%3.13M | 10.57%3.3M | --2.98M |
| -Depreciation and amortization | -5.16%3.13M | 10.57%3.3M | --2.98M |
| Other operating expenses | -78.30%1.02M | 137.56%4.68M | --1.97M |
| Operating profit | -6.12%-36.62M | -73.27%-34.51M | -19.92M |
| Net non-operating interest income (expenses) | -1,190.68%-642.89K | 100.63%58.94K | -9.35M |
| Non-operating interest income | ---- | --145.04K | ---- |
| Non-operating interest expense | 646.75%642.89K | -99.08%86.09K | --9.35M |
| Other net income (expenses) | -8,436.22%-10.59M | 87.94%-124.05K | -1.03M |
| Special income (charges) | 52.29%-1.48M | ---3.1M | ---- |
| -Less:Impairment of capital assets | -52.29%1.48M | --3.1M | ---- |
| Other non-operating income (expenses) | -406.12%-9.11M | 389.35%2.98M | ---1.03M |
| Income before tax | -38.41%-47.85M | -14.12%-34.57M | -30.29M |
| Income tax | 153.56%96.36K | -14.40%38.01K | 44.4K |
| Earnings from equity interest net of tax | |||
| Net income | -38.54%-47.95M | -14.08%-34.61M | -30.34M |
| Net income continuous operations | -38.54%-47.95M | -14.08%-34.61M | ---30.34M |
| Noncontrolling interests | |||
| Net income attributable to the company | -38.54%-47.95M | -14.08%-34.61M | -30.34M |
| Preferred stock dividends | |||
| Other under preferred stock dividend | |||
| Net income attributable to common stockholders | -38.54%-47.95M | -14.08%-34.61M | -30.34M |
| Diluted earnings per share | -16.08%-0.1241 | 30.05%-0.1069 | -0.1528 |
| Basic earnings per share | -16.08%-0.1241 | 30.05%-0.1069 | -0.1528 |
| Dividend per share | |||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data